XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

Restructuring Costs | 6 Months Ended
--- | ---
Jun. 30, 2025
Restructuring Costs [Abstract] |
Restructuring Costs | 14. RESTRUCTURING COSTS In February 2025, management approved a new restructuring plan in furtherance of our ongoing program to improve operating performance. The restructuring plan primarily impacts our operations in the U.S. and includes the elimination of certain positions, the consolidation of certain functions, and the relocation of certain operations to lower cost locations. Our February 2025 restructuring plan is expected to be substantially completed by the end of 2025. In addition to the below restructuring plan reserve activity, management recorded $4.1 million of restructuring expense related to facility exit costs, primarily impacting the Clinical Diagnostics segment. From February 2025 to June 30, 2025, total restructuring-related expenses for our February 2025 restructuring plan was $37.4 million, primarily representing estimated termination benefits to employees. The adjustments to expense recorded during the six months ended June 30, 2025 were primarily due to changes in the estimates of employee termination benefits of our previously announced restructuring plans, and the timing of the remaining employee termination benefit payments is in accordance with statutory requirements. The following table summarizes the activity of our total restructuring reserves (in millions):
|  | Life Science |  | Clinical Diagnostics |  | Total
Balances as of December 31, 2024: |  | $ | 2.0 |  |  | $ | 13.0 |  |  | $ | 15.0 |
Charged to expense - employee termination benefits |  | 15.4 |  |  | 16.0 |  |  | 31.4 |
Adjustments to expense |  | 0.6 |  |  | (0.5) |  |  | 0.1 |
Cash payments |  | (13.8) |  |  | (14.4) |  |  | (28.2) |
Foreign currency adjustments |  | 0.2 |  |  | 1.7 |  |  | 1.9 |
Balances as of June 30, 2025: |  | $ | 4.4 |  |  | $ | 15.8 |  |  | $ | 20.2 |
The accrued restructuring plan reserve of $20.2 million as of June 30, 2025 was recorded in Accrued payroll and employee benefits in the condensed consolidated balance sheets. Restructuring-related expense is allocated in the condensed consolidated statements of income (loss) as follows (in millions):
| Three Months Ended |  | Six Months Ended
| June 30 |  | June 30
| 2025 |  | 2024 |  | 2025 |  | 2024
Cost of goods sold | $ | 0.1 |  |  | $ | 0.6 |  |  | $ | 4.7 |  |  | $ | 1.1 |
Selling, general and administrative expense | 2.6 |  |  | (1.4) |  |  | 17.9 |  |  | 3.1 |
Research and development expense | (0.3) |  |  | (0.6) |  |  | 13.0 |  |  | 1.5 |
Total restructuring expense | $ | 2.4 |  |  | $ | (1.4) |  |  | $ | 35.6 |  |  | $ | 5.7 |

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration